Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Existe información en español para pacientes y cuidadores, para acceder, haga clic sobre “Select” al lado de “I am a U.S. Patient / Caregiver”.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

Levofloxacin in 5% Dextrose Injection, USP Principal Display Panel

PRINCIPAL DISPLAY PANEL - 50 mL Bag Label

NDC 0409-0528-13

50 mL
LEVO
FLOXACIN
IN 5% DEXTROSE INJECTION 250 mg (5 mg/mL)

250 mg in 50 mL 5% Dextrose

USE IMMEDIATELY ONCE REMOVED FROM THE OVERWRAP
INFUSE OVER 60 MINUTES

FOR INTRAVENOUS INFUSION

No further dilution is necessary. Each 50 mL contains
a dilute solution equivalent of 250 mg of levofloxacin
(5 mg/mL) in 5% Dextrose. May contain Hydrochloric
Acid, NF and/or Sodium Hydroxide, NF to adjust pH to
3.8 – 5.8. Additives should not be added or infused
simultaneously through the same intravenous line.
Single-use container. Any unused portion should be
discarded. Usual Adult Dosage: See Insert.
Sterile,
nonpyrogenic. Use only if solution is clear and
container is undamaged. Must not be used in series
connection.
Avoid excessive heat.

RX ONLY

3
V

CONTAINS DEHP

PRINTED IN USA
IM-1639 (10/07)

Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

PRINCIPAL DISPLAY PANEL - 50 mL Bag Label

PRINCIPAL DISPLAY PANEL - 50 mL Bag Pouch

TO OPEN - TEAR AT NOTCH
ONE UNIT / NDC 0409-0528-13

50 mL
LEVO
FLOXACIN
IN 5% DEXTROSE INJECTION 250 mg (5 mg/mL)

250 mg in 50 mL 5% Dextrose

ATTENTION PHARMACIST: DISPENSE THE ACCOMPANYING
MEDICATION GUIDE TO EACH PATIENT.

FOR INTRAVENOUS INFUSION
INFUSE OVER 60 MINUTES

LEAVE BAG IN OVERWRAP UNTIL USE.

Each 50 mL contains a dilute solution equivalent of 250 mg of levofloxacin (5 mg/mL) in
5% Dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF for pH
adjustment. pH range 3.8 – 5.8.
Usual Adult Dosage: See Insert. Store at 20 to 25°C (68 to 77°F). [See USP Controlled
Room Temperature.] Product may also be stored in a refrigerator, 2 to 8°C (36 to 46°F).
Avoid excessive heat. Protect from light. Protect from freezing.
Single-use container. Any unused portion should be discarded. Must not be used in
series connection. Additives should not be added or infused through the same
intravenous line. The overwrap is a moisture barrier. Do not remove unit from overwrap
until ready to use. Use unit promptly when pouch is open. After removing the overwrap,
check for minute leaks by squeezing container firmly. If leaks are found, discard unit as
sterility may be impaired. Use only if solution is clear and the container is undamaged.
NO FURTHER DILUTION IS NECESSARY.

RX ONLY

F WR-1522

7
OTHER

Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

PRINCIPAL DISPLAY PANEL - 50 mL Bag Pouch

PRINCIPAL DISPLAY PANEL - 100 mL Bag Label

NDC 0409-0528-23

100 mL
LEVO
FLOXACIN
IN 5% DEXTROSE INJECTION 500 mg (5 mg/mL)

500 mg in 100 mL 5% Dextrose

USE IMMEDIATELY ONCE REMOVED FROM THE OVERWRAP
INFUSE OVER 60 MINUTES

FOR INTRAVENOUS INFUSION

No further dilution is necessary. Each 100 mL
contains a dilute solution equivalent of 500 mg of
levofloxacin (5 mg/mL) in 5% Dextrose. May contain
Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to
adjust pH to 3.8 – 5.8. Additives should not be added
or infused simultaneously through the same
intravenous line. Single-use container. Any unused
portion should be discarded. Usual Adult Dosage: See
Insert.
Sterile, nonpyrogenic. Use only if solution is
clear and container is undamaged. Must not be used
in series connection.
Avoid excessive heat.

RX ONLY

3
V

CONTAINS DEHP

PRINTED IN USA
IM-1640 (10/07)

Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

PRINCIPAL DISPLAY PANEL - 100 mL Bag Label

PRINCIPAL DISPLAY PANEL - 100 mL Bag Pouch

TO OPEN - TEAR AT NOTCH
ONE UNIT / NDC 0409-0528-23

100 mL
LEVO
FLOXACIN
IN 5% DEXTROSE INJECTION 500 mg (5 mg/mL)

500 mg in 100 mL 5% Dextrose

ATTENTION PHARMACIST: DISPENSE THE ACCOMPANYING
MEDICATION GUIDE TO EACH PATIENT.

FOR INTRAVENOUS INFUSION
INFUSE OVER 60 MINUTES

LEAVE BAG IN OVERWRAP UNTIL USE.

Each 100 mL contains a dilute solution equivalent of 500 mg of levofloxacin (5 mg/mL)
in 5% Dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF for
pH adjustment. pH range 3.8 – 5.8.
Usual Adult Dosage: See Insert. Store at 20 to 25°C (68 to 77°F). [See USP Controlled
Room Temperature.] Product may also be stored in a refrigerator, 2 to 8°C (36 to 46°F).
Avoid excessive heat. Protect from light. Protect from freezing.
Single-use container. Any unused portion should be discarded. Must not be used in
series connection. Additives should not be added or infused through the same
intravenous line. The overwrap is a moisture barrier. Do not remove unit from
overwrap until ready to use. Use unit promptly when pouch is open. After removing
the overwrap, check for minute leaks by squeezing container firmly. If leaks are found,
discard unit as sterility may be impaired. Use only if solution is clear and the container
is undamaged. NO FURTHER DILUTION IS NECESSARY.

RX ONLY

F WR-1523

7
other

Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

PRINCIPAL DISPLAY PANEL - 100 mL Bag Pouch

PRINCIPAL DISPLAY PANEL - 150 mL Bag Label

NDC 0409-0528-31

150 mL
LEVO
FLOXACIN
IN 5% DEXTROSE INJECTION 750 mg (5 mg/mL)

750 mg in 150 mL 5% Dextrose

USE IMMEDIATELY ONCE REMOVED FROM THE OVERWRAP
INFUSE OVER 90 MINUTES

FOR INTRAVENOUS INFUSION

No further dilution is necessary. Each
150 mL contains a dilute solution equivalent
of 750 mg of levofloxacin (5 mg/mL) in 5%
Dextrose. May contain Hydrochloric Acid,
NF and/or Sodium Hydroxide, NF to adjust
pH to 3.8 – 5.8. Additives should not be
added or infused simultaneously through
the same intravenous line. Single-use
container. Any unused portion should be
discarded. Usual Adult Dosage: See Insert.

Sterile, nonpyrogenic. Use only if solution is
clear and container is undamaged. Must not
be used in series connection.
Avoid
excessive heat.

RX ONLY

3
V

CONTAINS DEHP

PRINTED IN USA
IM-1641 (10/07)

Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

PRINCIPAL DISPLAY PANEL - 150 mL Bag Label

PRINCIPAL DISPLAY PANEL - 150 mL Bag Pouch

TO OPEN - TEAR AT NOTCH
ONE UNIT / NDC 0409-0528-31

150 mL
LEVO
FLOXACIN
IN 5% DEXTROSE INJECTION 750 mg (5 mg/mL)

750 mg in 150 mL 5% Dextrose

ATTENTION PHARMACIST: DISPENSE THE ACCOMPANYING
MEDICATION GUIDE TO EACH PATIENT.

FOR INTRAVENOUS INFUSION
INFUSE OVER 90 MINUTES

LEAVE BAG IN OVERWRAP UNTIL USE.

Each 150 mL contains a dilute solution equivalent of
750 mg of levofloxacin (5 mg/mL) in 5% Dextrose.
May contain Hydrochloric Acid, NF and/or Sodium
Hydroxide, NF for pH adjustment. pH range 3.8 – 5.8.
Usual Adult Dosage: See Insert. Store at 20 to 25°C
(68 to 77°F). [See USP Controlled Room Temperature.]
Product may also be stored in a refrigerator, 2 to 8°C
(36 to 46°F). Avoid excessive heat. Protect from light.
Protect from freezing.
Single-use container. Any unused portion should be
discarded. Must not be used in series connection.
Additives should not be added or infused through
the same intravenous line. The overwrap is a moisture
barrier. Do not remove unit from overwrap until ready
to use. Use unit promptly when pouch is open. After
removing the overwrap, check for minute leaks by
squeezing container firmly. If leaks are found, discard
unit as sterility may be impaired. Use only if solution is
clear and the container is undamaged. NO FURTHER
DILUTION IS NECESSARY.

RX ONLY

F WR-1524

7
other

Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

PRINCIPAL DISPLAY PANEL - 150 mL Bag Pouch
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event